Literature DB >> 17556720

Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?

Brent W Kinder1, Harold R Collard, Laura Koth, David I Daikh, Paul J Wolters, Brett Elicker, Kirk D Jones, Talmadge E King.   

Abstract

RATIONALE: The American Thoracic Society/European Respiratory Society International Consensus Classification panel identified the clinical entity idiopathic nonspecific interstitial pneumonia (NSIP) as a provisional diagnosis and recommended further study.
OBJECTIVES: We hypothesized that idiopathic NSIP is an autoimmune disease and the lung manifestation of undifferentiated connective tissue disease (UCTD), a recently described, distinct entity.
METHODS: We studied 28 consecutive patients with idiopathic interstitial pneumonia (IIP) enrolled in the University of California, San Francisco Interstitial Lung Disease Center who met prespecified criteria for UCTD, as follows: at least one clinical manifestation of connective tissue disease, serologic evidence of systemic inflammation in the absence of clinical infection, and absence of sufficient American College of Rheumatology criteria for another connective tissue disease. Medical record reviews, evaluation of radiographs, and scoring of lung biopsies were performed. The control group consisted of all other patients (n = 47) with IIP who did not meet the UCTD criteria.
MEASUREMENTS AND MAIN RESULTS: The patients with UCTD were more likely to be women, younger, and nonsmokers than the IIP control subjects. Compared with the control group, patients with UCTD-ILD were significantly more likely to have ground-glass opacity on high-resolution computed tomography (HRCT) and NSIP pattern on biopsy, and less likely to have honeycombing on HRCT or usual interstitial pneumonia on biopsy. At our center, the majority of patients classified as idiopathic NSIP (88%) met the criteria for UCTD.
CONCLUSIONS: Most patients diagnosed with idiopathic NSIP meet the case definition of UCTD. Furthermore, these results show that the clinical entity idiopathic NSIP is different from idiopathic pulmonary fibrosis and appears to be an autoimmune disease.

Entities:  

Mesh:

Year:  2007        PMID: 17556720      PMCID: PMC1994238          DOI: 10.1164/rccm.200702-220OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

1.  Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.

Authors:  H J Williams; G S Alarcon; R Joks; V D Steen; K Bulpitt; D O Clegg; C M Ziminski; M E Luggen; E W St Clair; R F Willkens; C Yarboro; J G Morgan; M J Egger; J R Ward
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

Review 2.  Nonspecific interstitial pneumonia: a real clinical entity?

Authors:  Sonoko Nagai; Tomohiro Handa; Rollin Tabuena; Masanori Kitaichi; Takateru Izumi
Journal:  Clin Chest Med       Date:  2004-12       Impact factor: 2.878

3.  Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both?

Authors:  Andrea Doria; Marta Mosca; Pier Franca Gambari; Stefano Bombardieri
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

4.  Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia".

Authors:  Jiro Fujita; Yuji Ohtsuki; Takeo Yoshinouchi; Ichiro Yamadori; Shuji Bandoh; Michiaki Tokuda; Hiroshi Miyawaki; Nobuhito Kishimoto; Toshihiko Ishida
Journal:  Respir Med       Date:  2005-02       Impact factor: 3.415

5.  Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.

Authors:  S Nagai; M Kitaichi; H Itoh; K Nishimura; T Izumi; T V Colby
Journal:  Eur Respir J       Date:  1998-11       Impact factor: 16.671

6.  Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD.

Authors:  M G Danieli; P Fraticelli; A Salvi; A Gabrielli; G Danieli
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.

Authors:  M Mosca; A Tavoni; R Neri; W Bencivelli; S Bombardieri
Journal:  Lupus       Date:  1998       Impact factor: 2.911

8.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.

Authors:  Z D Daniil; F C Gilchrist; A G Nicholson; D M Hansell; J Harris; T V Colby; R M du Bois
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

9.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.

Authors:  J A Bjoraker; J H Ryu; M K Edwin; J L Myers; H D Tazelaar; D R Schroeder; K P Offord
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

10.  Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study.

Authors:  Isao Ito; Sonoko Nagai; Masanori Kitaichi; Andrew G Nicholson; Takeshi Johkoh; Satoshi Noma; Dong Soon Kim; Tomohiro Handa; Takateru Izumi; Michiaki Mishima
Journal:  Am J Respir Crit Care Med       Date:  2004-12-03       Impact factor: 21.405

View more
  82 in total

1.  Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease.

Authors:  Naomi J Lohr; Jean P Molleston; Kevin A Strauss; Wilfredo Torres-Martinez; Eric A Sherman; Robert H Squires; Nicholas L Rider; Kudakwashe R Chikwava; Oscar W Cummings; D Holmes Morton; Erik G Puffenberger
Journal:  Am J Hum Genet       Date:  2010-02-18       Impact factor: 11.025

2.  Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis.

Authors:  Yasunori Ichimura; Kenji Tsushima; Takuma Matsumura; Kazutaka Yamagishi; Mitsuhiro Abe; Jun Ikari; Jiro Terada; Koichiro Tastumi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Risk of progression of interstitial pneumonia with autoimmune features to a systemic autoimmune rheumatic disease.

Authors:  Michail K Alevizos; Jon T Giles; Nina M Patel; Elana J Bernstein
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

4.  Characterisation of patients with interstitial pneumonia with autoimmune features.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Eleanor Valenzi; Cathryn Lee; Leah Witt; Lena Chen; Aliya N Husain; Steven Montner; Jonathan H Chung; Vincent Cottin; Aryeh Fischer; Imre Noth; Rekha Vij; Mary E Strek
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

5.  Clinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia.

Authors:  Esam H Alhamad
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

6.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

7.  Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Justin M Oldham; Disha Kumar; Cathryn Lee; Shruti B Patel; Stephenie Takahashi-Manns; Carley Demchuk; Mary E Strek; Imre Noth
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

8.  Autoimmune-featured interstitial lung disease: a distinct entity.

Authors:  Rekha Vij; Imre Noth; Mary E Strek
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

Review 9.  Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.

Authors:  Flavia V Castelino; John Varga
Journal:  Arthritis Res Ther       Date:  2010-08-23       Impact factor: 5.156

10.  Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function.

Authors:  Brent W Kinder; Cyrus Shariat; Harold R Collard; Laura L Koth; Paul J Wolters; Jeffrey A Golden; Ralph J Panos; Talmadge E King
Journal:  Lung       Date:  2010-04       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.